NCT02856100View on ClinicalTrials.gov

Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

August 3, 2016

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2020

Conditions
Prostate Cancer
Interventions
DRUG

18F DCFPyL- Radiopharmaceutical

Trial Locations (1)

21287

Johns Hopkins University, Baltimore

All Listed Sponsors
collaborator

Prostate Cancer Foundation

OTHER

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT02856100 - Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate Cancer | Biotech Hunter | Biotech Hunter